The current price is in 6,79$, In this post we are going to talk about the listed company BioCryst Pharmaceuticals Inc, its leaders are Anthony Doyle (Chief Financial Officer & Senior Vice President), Helen M. Thackray (Director, Chief Research & Development Officer), Jon P. Stonehouse (President, Chief Executive Officer & Director), William P. Sheridan (Chief Medical Officer & Senior Vice President), they lead it to work in Biotechnology: Biological Products (No Diagnostic Substances) especially in the North America region.
Today this action begins with yesterday's closing price, desconocido$.
With an intraday difference of 6,78$ moving between 6,67$ and 6,90$, it is a notable difference that allows quick purchases and sales.
The company has an annual revenue of desconocido.
The last value we have registered for the opening is desconocido.
To detect if it is a good time to enter or exit a stock, many traders use the lowest and highest values of the last 52 weeks. In this action, prices have moved between 0,00$ and 0,00$.
The EPS, or net profit divided by the number of shares in progress, tells us with a high value that we must enter and with a low value that we must leave, it is a result of how the company has done in the last year.
Buscar
